THE AETIOLOGY OF CHRONIC KIDNEY DIEASE IN MAIDUGURI, NIGERIA UMMATE I, NWANKWO E, YUSUF H

Similar documents
Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

AWARENESS LEVEL OF KIDNEY DISEASES AMONG NON-MEDICAL STUDENTS IN BENIN CITY, NIGERIA

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

Prevalence of chronic renal failure in adults in Delhi, India

PREVALENCE AND TYPES OF INTRA-DIALYTIC COMPLICATIONS IN PATIENTS DIALYSING AT THE UNIVERSITY OF BENIN TEACHING HOSPITAL

The 15 th Emerging New Researchers in the Geography of Health and Impairment Conference June Paris France

Research Article The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in South-East Nigeria

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: Is there a change in trend?

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

ORIGINAL ARTICLE Correlation Between Aetiology, Stage and Duration of Chronic Kidney Disease and Hearing Loss Adekwu A 1, Ibiam F A 2, Ogbeyi G A 3, A

Pattern of Glomerular Diseases in Gombe, Northeastern Nigeria

AJNT. Special Article. Renal Replacement Therapy in Sudan, Sarra Elamin 1*, Wafaa Obeid 2, Hasan Abu-Aisha 1. Abstract

Introduction. 1. Introduction

The CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function

Epidemiology of CKD in Children

Maolynne Miller Paediatric Nephrologist UHWI Jamaica Kidney Kids Foundation/ International Paediatric Nephrology Association 1st Jamaican Paediatric

OUTLINE INTRODUCTION EPIDEMIOLOGY CLASSIFICATION DIAGNOSIS AETIOLOGY MANAGEMENT FINANCIAL BURDEN OF ESRD SCREENIG GUIDELINE CONCLUSION

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

WaSH PiN Methodology. WaSH Sector, 2017

Contrast Induced Nephropathy

Pharmacological Management of Complications of End Stage Renal Disease in Patients on Maintenance Hemodialysis.

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

PREVALENCE AND CLINICAL PRESENTATION OF CYSTIC KIDNEY DISEASES AT LAGOS STATE UNIVERSITY TEACHING HOSPITAL

New Treatments for ADPKD how close are we?

Chapter 1. Incidence of End Stage Kidney Disease. Contents:

Analysis of spectrum of chronic kidney disease in IPD and OPD

Long-term outcomes in nondiabetic chronic kidney disease

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

SONOGRAPHIC GRADING OF RENAL CORTICAL ECHOGENICITY AND RAISED SERUM CREATININE IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Dialysis Mortality Regional Clinical Audit Report 2011

Chronic Kidney Disease of Uncertain Aetiology - Clinical Features. Dr. Tilak Abeysekera Consultant Nephrologist

Special Challenges and Co-Morbidities

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Update on HIV-Related Kidney Diseases. Agenda

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

AWARENESS OF HYPERTENSION AND ITS RISK FACTORS IN MAIDUGURI, NORTH EASTERN NIGERIA

UNITED NATIONS HIGH-LEVEL MEETING ON NCDs A CALL TO ACTION ON KIDNEY DISEASE. Advancing Nephrology Around the World

Chronic Kidney Disease: Optimal and Coordinated Management

Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

Management of End Stage Renal Disease-Bangladesh Perspective

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Rosnawati Yahya. Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng.

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

World Congress of Nephrology, Mexico City

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

Chronic Kidney Disease

Your Kidneys: Master Chemists of the Body

Chapter IV. Incidence and Causes of Treated ESRD. Methods

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

The role of the Nephrologist in Acute Kidney Injury. Rebecca Brown Consultant Nephrologist Royal Liverpool University Hospital

Chapter 2: Identification and Care of Patients With CKD

Chronic kidney disease the silent epidemic

Resident Doctors Knowledge and Practice of Chronic Kidney Disease: Diagnosis and Referral Pattern

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

CHAPTER 14. Renal Transplantation

THE KIDNEY AND SLE LUPUS NEPHRITIS

1. Reggie J. Divina, M.D. (1) 2. Fe S. Felicilda, M.D., DPBCN (1,2) 3. Rufino E. Chan, M.D. (1) 4. Luisito O. Llido, M.D.

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

End stage renal disease (ESRD) is a common and. Incidence of end stage renal disease on renal replacement therapy in Nepal ( ) Audit

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Chronic Kidney Disease

Chronic Kidney Disease - An Overview

Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment

Echocardiographic assessment of left ventricular hypertrophy in patients of chronic kidney disease

The UK Renal Registry collects national data about the causes and treatment of kidney failure.

Educational Goals & Objectives

USRDS UNITED STATES RENAL DATA SYSTEM

Chapter - 2 DIALYSIS IN MALAYSIA

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)


Chapter 2: Identification and Care of Patients with CKD

Chronic renal disease in the elderly: are all pigs to be considered equal?

Study of association of serum bicarbonate levels with mortality in chronic kidney disease

KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

Chronic Renal Failure in Khartoum, Sudan

STATEMENT OF THE NATIONAL KIDNEY FOUNDATION SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS;

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Chronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham

AJNT. Original Article

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009

Building a clinical service for children with CKD in a developing country

Screening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!

Professor Suetonia Palmer

CHAPTER 2. Dialysis in Malaysia

Christian Aid (JDF), MC, OXFAM(CSCPE), People Reached. Adamawa: 204, Organizations

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

East London Community Kidney Service

Haemodialysis: An Option for the Treatment of Renal Failure in F.C.T., Nigeria

The Health Problem: Guidelines: NHS Priority:

Transcription:

ORIGINAL ARTICLE Background: Chronic kidney disease (CKD) is a growing health problem worldwide. Objectives: To determine the aetiology of chronic kidney disease among haemodialysis requiring patients in the University of Maiduguri Teaching Hospital, Nigeria. Methods: A cross-sectional study of one hundred consecutive patients with stage 5 chronic kidney failure requiring haemodialysis at the university of Maiduguri teaching Hospital between January and December 2005. Their demographic data, clinical features, aetiology of the CKD, and laboratory data were recorded using a questionnaire administered by the investigators. rd th Results: There were 68 males (68%) and 32 females (32%) with most of the patients (53%) in their 3 and 4 decades of life. Majority (21%) were from Maiduguri metropolis. Fifteen (15%) of the study population came from Gashua, a town in the northern part of Yobe State. Gashua town has a CKD prevalence rate of 10.7/100,000 accounting to 45% of cases from Yobe State, the highest among the 17 Local Government Areas of the state. The aetiology of CKD was hypertension in 35%, chronic glomerulonephritis in 28%, and diabetes mellitus in 12% of the study population, but in 9% of the cases, the cause of CKD could not be ascertained, thus regarded as unclassified. THE AETIOLOGY OF CHRONIC KIDNEY DIEASE IN MAIDUGURI, NIGERIA UMMATE I, NWANKWO E, YUSUF H ABSTRACT Conclusion: Hypertension and GN were the commonest causes of CKD in this environment. Gashua town of Yobe State has a very high CKD prevalence rate. The reasons for this need to be investigated. INTRODUCTION The number of chronic kidney failure patients sustained by haemodialysis has been on the increase in Maiduguri perhaps due to the availability and increased awareness of renal replacement therapy by the people. Chronic kidney disease (CKD) is a growing health problem worldwide. Several published studies emphasize 1-4 that CKD is under diagnosed and undertreated. The public health and economic burdens of CKD continue to increase at an alarming rate with the incidence of End Stage Renal Disease (ERSD) estimated to be 7% and prevalent population of 1.1 million that is expected to top 2 million by 5 2010. It has been projected that the cost of renal replacement therapy will soon exceed 1 trillion dollars per annum globally at a patient per capital cost of over $55,000 6 in the US. The majority of ERSD patients receiving dialysis or transplantation reside in the rich industrialized countries whereas in developing countries like India despite the cheaper cost of haemodialysis, that modality of treatment is 7 largely unsustainable because of rampart poverty. Despite the high burden and associated high morbidity, the causes of CKD in a high percentage of individuals remain largely 8 elusive especially in developing countries where lack of modern diagnostic techniques and late presentation to nephrologists greatly limit the characterisation of kidney diseases. Those limitations have probably led to the misclassification of significant number of patients with the findings of bilaterally contracted kidneys as chronic glomerulonephritis. Therefore, recognition of this chronic condition is crucial to facilitate the employment of measures that can slow progression to end-stage renal 9 disease (ESRD). Also, appropriate and timely Affiliation: Department of Medicine, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria Correspondence and reprint request to: Dr Ummate I Nephrology Unit, Department of Medicine UMTH, Maiduguri, Nigeria. Tel: +2348035138334, +2348023552876. E-mail: dribrahimummate@yahoo.com 48 Kanem journal of medical sciences 2008;2(2):48-52

interventions in patients with CKD would enhance therapy of co-morbid conditions, reduce associated complications, 9 and improve patient outcomes. This study was therefore aimed at determining the causes of chronic kidney disease among our haemodialysis requiring patients. MATERIALS AND METHODS Study Area This study was carried out at the University of Maiduguri Teaching Hospital (UMTH), Maiduguri, Nigeria. Maiduguri is the capital of Borno state in north-eastern Nigeria with a population of about 0.7 million. It lies 0 0 between latitude 11.5 N and 13.5 N in the Sudan savannah. Study Design/Subjects This was a cross-sectional study carried out between January and December 2005. One hundred consecutive patients with stage 5 chronic kidney failure attending the nephrology clinic or admitted into the medical wards of the University of Maiduguri Teaching Hospital were recruited for the study. Patient's demographic data were recorded on a questionnaire administered by the investigators. Other parameters recorded include clinical features, aetiology of the CKD, and laboratory data. Patient Evaluation Detailed history of the patients' clinical condition was taken. Patients were subsequently examined. Blood samples were obtained at entry for creatinine clearance, serum electrolytes including calcium and phosphate, urea and creatinine, liver function tests, HIV screening, HCV abs, HbsAg and full blood count (FBC). Estimated glomerular filtration rate (egfr) was obtained by 10 calculation using Cockroft and Gault equation. Abdominal ultrasound scan was also done on all those recruited for the study. Those with previous history of AGN, streptococcal sore throat, streptococcal skin infection, elevated ASO titre, or haematuria following throat or skin infection were considered to have CGN if presented with bilaterally shrunken kidneys and do not have evidences of other organ involvement of hypertension or diabetes. Long standing hypertension or diabetes mellitus with renal involvement particularly with evidence of other end organ damage formed the criteria for the diagnosis of hypertensive nephropathy and diabetic nephropathy respectively. Additionally the findings of normal sized kidneys bilaterally in diabetic patients with nephropathy strengthen our suspicion of diabetic nephropathy. Diagnosis of polycystic kidney disease, medullary sponge kidneys, obstructive uropathy were based on documented 11-13 clinical and radiologic criteria. Those patients whose cause of CKD could not be established after thorough evaluations were regarded as unclassified. RESULTS One hundred consecutive kidney failure patients made up of 68 males (68%) and 32 females (32%) were enrolled into rd th the study. Most of the patients (53%) were in their 3 and 4 decades of life. Their ages ranged between 15 and 74 years with a mean ± SD of 39.9 ± 13.58 years. The mean ± SD age of the male patients was 41.71 ± 13.27 years and that of female patients was 36.06 ± 13.64 years (Table 1). Majority of the study population (21%) were from Maiduguri metropolis, which is a cosmopolitan town with a population of 0.7 million. Fifteen (15%) of the study population came from Gashua, a town in the northern part of Yobe State, 10 (10%) from Kanuri dominated villages of northern Borno, 9 (9%) from Yola and other towns around it, 7 (7%) from Biu and surrounding villages, while 6 (6%) each were from Nguru and Potiskum, and 5 (5%) each from Damaturu, Hong, Kaltungo and Katagum, respectively. There were 3, 2 and 1 patients each from Michika, Wukari and Bama, respectively. This was illustrated in Table 2. We projected in this hospital study an estimate of the population prevalence per 100,000 that Gashua town has a prevalence rate of 10.7/100,000, Yobe state 1.68/100,000, Borno state 0.87/100,000, Adamawa 0.42/100,000, Gombe 0.17/100,000, Taraba 0.12/100,000 and Bauchi 0.10/100,000. Those from Gashua accounts for 45% of patients from Yobe State (Table 3). The aetiology of the CKD was hypertension in 35% of the patients, CGN in 28% and diabetes mellitus in 12%. Pyelonephritis 4%, polycystic kidney disease 3%, analgesic and toxic nephropathy 3%, Alport's syndrome and obstructive uropathy accounted for 2% each, while sickle cell nephropathy and medullary sponge kidneys accounted for 1%, (Table 4). Nine percent of the study patients had CKD of uncertain cause in this study because we could not pinpoint any cause of kidney failure in them. Normal kidney sizes was detected on ultrasound scan in all the patients with diabetic nephropathy, pyelonephritis, ADPKD, sickle cell nephropathy, medullary sponge kidneys, and 1 of 3 patients with 49 Kanem journal of medical sciences 2008;2(2):48-52

analgesic and toxic nephropathy. All patients with hypertensive nephropathy, CGN, Alport syndrome, obstructive nephropathy, kidney disease of unknown etiology, and 2 patients with analgesic and toxic nephropathies had shrunken kidneys. (Table 5). There is increased cortical echogenicity with corticomedullary differentiation ranging from poor to complete loss in the study group, except in patients with ADPKD where the corticomedullary picture could not be Table 1. Age and sex distribution of study patients Age (yrs) Sex Total n (%) Male n (%) Female n (%) =19 3 (3%) 3 (3%) 6 (6%) 20-29 9 (9%) 8 (8%) 17 (17%) 30-39 17 (17%) 7 (7%) 24 (24%) 40-49 20 (20%) 9 (9%) 29 (29%) 50-59 11 (11%) 3 (3%) 14 (14%) 60-69 6 (6%) 2 (2%) 8 (8%) =70 2 (2%) 0 (0%) 2 (2%) Table 3. Cases per 100,000 populations according to geographical location States Cases (n) Cases (%) Cases/100,000 Borno 39 39% 0.87* Population Yobe 32 32% 1.68** Adamawa 17 17% 0.42 Gombe 5 5% 0.17 Bauchi 5 5% 0.10 Taraba 2 2% 0.12 Total 100 100% Gashua 15 15% of total patients 10.7*** *High prevalence rate 45% of Yobe state patients are from Gashua **Very high prevalence rate ***Extremely high prevalence rate Total 68 (68%) 32 (32%) 100 (100%) Table 2. Geographical location of study patients Geographical location Frequency (n) Percentage (%) of study patients Maiduguri 21 21 Gashua 15 15 Kanuri villages 10 10 Yola and villages 9 9 Biu and surrounding Villages 7 7 Nguru 6 6 Potiskum 6 6 Damaturu 5 5 Hong 5 5 Kaltungo 5 5 Katagum 5 5 Michika 3 3 Wukari 2 2 Bama 1 1 Table 4. Aetiologies of CKD in the study population Aetiology of CKD Frequency (n) Percentage (%) Hypertension 35 35 CGN 28 28 Diabetes mellitus 12 12 Pyelonephritis 4 4 Polycystic kidney disease 3 3 Analgesics and toxins 3 3 Alport syndrome 2 2 Obstructive uropathy 2 2 Sickle cell disease 1 1 Medullary sponge kidneys 1 1 Unclassified 9 9 Total 100 100 Total 100 100 50 Kanem journal of medical sciences 2008;2(2):48-52

Table 5. Kidney sizes and corticomedullary picture of study population Etiology of CKD Kidney sizes Corticomedullary dif properly assessed because of multiple renal cysts (Table 5). DISCUSSION We found hypertension and CGN to be the commonest causes of CKD in our study population. This is in agreement 14 15 with findings of Akinsola et al, Ojogwu et al, and Kadiri 16 et al at Ile-Ife, Benin and Ibadan respectively. Diabetes mellitus, which is the commonest cause of CKD in Europe 17, 18 and America, was the found to be the distant third commonest cause of CKD in this study. Other aetiologies of CKD in this study are pyelonephritis, polycystic kidney disease, analgesics and toxins, Alport syndrome, obstructive uropathy, sickle cell disease and Medullary sponge kidney. Normal(n) Shrunken(n) Poor(n) Lost(n) Hypertension 0 35 29 6 CGN 0 28 18 10 Diabetes mellitus 12 0 11 1 Pyelonephritis 4 0 4 0 Polycystic kidney Disease 3 0 - - Analgesics and Toxins 1 2 2 1 Obstructive uropathy 0 2 1 1 Alport syndrome 0 2 2 0 Sickle cell disease 1 0 1 1 Medullary sponge Kidneys 1 0 1 0 Unknown 0 9 0 9 Ojogwu et al did a prospective study of 1,980 patients with ESRD over a six year period. Using information derived from intravenous pyelogram, ultrasonography, renal biopsies and autopsies, they found out that 43% of cases of chronic renal failure were due to hypertensive nephrosclerosis. Several factors could have been responsible for the finding of hypertension as the commonest cause of CKD in Nigeria. One such factor is the fact that high blood pressure is a major health problem in Blacks, with a 19 prevalence of 33% in Afro-Caribbean in America. Secondly, the development of renal failure is twenty times more likely in Black hypertensives aged 40-44yrs than in 19 Whites. The high prevalence of CKD among residents of Gashua is a finding which needs to be further looked into. All those we termed unclassified are residents of Gashua town. LIMITATIONS OF THE STUDY 1. Individuals recruited into the study were all haemodialysis requiring CKD patients because that was the common presentation in our centre. 2. Although only a few of the patients fulfill the criteria for renal biopsy, none had one done. CONCLUSIONS AND RECOMMENDATION The commonest cause of CKD in this study is hypertension. Demographically, most of the patients we see with CKD in this study are in their productive age group. Gashua town of Yobe State has the highest CKD prevalence rate in this study. Public enlightenment campaign and awareness creation on hypertension and its sequellae should be embarked upon by Nephrologists in Nigeria. Optimal management of hypertension is a key to successful prevention of end organ damages of hypertension. The cause of the high CKD prevalence rate in Gashua town REFERENCES 1. Obrator GT, Ruthazer R, Arora P et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999; 10:1793-1800. 2. Kausz AT, Khan SS, Abichandami R et al. Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol 2001; 12:1501-1507. 3. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatitine: who are we missing? Nephrol Dial Transplant 2001; 16:1042-1046. 4. Nissenson AR, Collins AJ, Hurley J et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001; 12:1713-1720. 5. Moeller S, Gioberge S, Brown G. ESRD patients in 2002. Global overview of patients treatment modalities and development trends. Nehprol Dial Transplant 2002; 17:2071-2076. 6. Lysart MJ. Maintenance dialysis population dynamics: Current trends and long term implications. J Am Soc Nephrol 2002; 13:37-40. 7. Kher V. End Stage Renal Disease in developing countries. Kidney Int 2002; 62:350-362. 51 Kanem journal of medical sciences 2008;2(2):48-52

8. Perneger TV, Brancati FL, Whelton PK, et al: Studying the causes of kidney disease in humans; a review of methodological obstacles and solutions. Am J Kidney Dis 1995; 25:722-731. 9. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Initiative. Am J Kidney Dis 2002; 39(Suppl2):S1-246. 10. Sanusi AA, Akinsola AA, Ajayi AA. Creatinine clearance estimation from serum creatinine values; Evaluation and comparison of five prediction formulae in Nigerian patients. Afr J Med 2000; 29: 7-11. 11. Ravine D, Gibson RN, Walker RG et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827. 12. Tori L, Kim Micheal. Medullary sponge kidney: An imaging study. J Diag Med Sonography May/June 2005; 21(3): 247-252. 13. Webb JA. Regular review. Ultrasonography in diagnosis of renal obstruction. BMJ 1990 Oct; 301(6758): 944-946. 14. Akinsola W, Odesanmi WO, Ogunniyi JO et al. Diseases causing chronic kidney failure in Nigerians- a prospective study of 100 cases. Afr J Med Sci 1989 Jan; 18(2): 131-7. 15. Ojogwu LI: The pathological basis of end stage renal disease in Nigerians; experience from Benin City. West Afr J Med 1990 Jul-Sep; 9(3): 193-196. 16. Kadiri S, Ayodele OE, Salako BL et al. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure. Afr J Med Sci 2002 Dec; 31(4): 311-4. 17.Amos AF, McCarty DJ, Zimmet P. The Rising Global Burden of Diabetes and its complications: Estimates and Projections to the year 2010. Diabet Med 1997; 14 (suppl5): s1-85. 18. Ansell D, Feest TG. Fifty annual report of the UK renal registry. Bristol: Renal Association and UK Renal Registry 2002. 19. Collins R, MacMahon S. Blood Pressure, Antihypertensive Drug Treatment and the Risks of Stroke and Coronary Heart Disease. Br Med Bull 1994; 50: 272-298. 52 Kanem journal of medical sciences 2008;2(2):48-52